317 related articles for article (PubMed ID: 32086242)
1. Clinical Translation of a
Feng X; Wang Y; Lu D; Xu X; Zhou X; Zhang H; Zhang T; Zhu H; Yang Z; Wang F; Li N; Liu Z
J Nucl Med; 2020 Oct; 61(10):1461-1467. PubMed ID: 32086242
[TBL] [Abstract][Full Text] [Related]
2. PET/CT Imaging of NSCLC with a α
Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of
Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the RGD Motif-Containing α
Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Copper-64-Labeled α
Ganguly T; Bauer N; Davis RA; Hausner SH; Tang SY; Sutcliffe JL
Mol Pharm; 2021 Dec; 18(12):4437-4447. PubMed ID: 34783573
[TBL] [Abstract][Full Text] [Related]
6. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
[TBL] [Abstract][Full Text] [Related]
8. Validation of In-House Kit-Like Synthesis of
Thakral P; Das SS; Dhiman S; Manda D; Virupakshappa CB; Malik D; Sen I
Cancer Biother Radiopharm; 2023 Sep; 38(7):468-474. PubMed ID: 37093129
[No Abstract] [Full Text] [Related]
9. Development and characterization of a
Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
[TBL] [Abstract][Full Text] [Related]
10. Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection.
Liu Z; Liu H; Ma T; Sun X; Shi J; Jia B; Sun Y; Zhan J; Zhang H; Zhu Z; Wang F
J Nucl Med; 2014 Jun; 55(6):989-94. PubMed ID: 24711651
[TBL] [Abstract][Full Text] [Related]
11. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma.
Müller M; Altmann A; Sauter M; Lindner T; Jäger D; Rathke H; Herold-Mende C; Marmé F; Babich J; Mier W; Haberkorn U
Nuklearmedizin; 2019 Aug; 58(4):309-318. PubMed ID: 31075798
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, preclinical, and initial clinical evaluation of integrin α
Wen X; Wang R; Xu P; Shi M; Shang Q; Zeng X; Zeng X; Liu J; Wang X; Zhu Z; Guo Z; Chen X; Zhang J
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2023-2035. PubMed ID: 38376806
[TBL] [Abstract][Full Text] [Related]
15.
Ren J; Zhu S; Zhang G; Tan X; Qiu L; Lin J; Jiang L
Mol Pharm; 2022 Jul; 19(7):2620-2628. PubMed ID: 35674464
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
[TBL] [Abstract][Full Text] [Related]
17. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids.
Nakamura S; Matsuno A; Ueda M
Ann Nucl Med; 2020 Aug; 34(8):575-582. PubMed ID: 32514725
[TBL] [Abstract][Full Text] [Related]
18. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Development and First-in-Human Imaging of the Integrin α
Hausner SH; Bold RJ; Cheuy LY; Chew HK; Daly ME; Davis RA; Foster CC; Kim EJ; Sutcliffe JL
Clin Cancer Res; 2019 Feb; 25(4):1206-1215. PubMed ID: 30401687
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
